Hepatitis B Vaccine

Trial Participants Try Intradermal Immunization

Published in Vaccine Weekly, June 7th, 2000

According to a Canadian study, higher-dose intradermal administration of the hepatitis B virus (HBV) vaccine may be a cost-effective, viable method for inoculating vaccine recipients.

Currently, the standard method for HBV vaccine administration is via the intramuscular route.

E.A. Henderson and others of Calgary General Hospital conducted the trial of more than 700 healthcare workers. The study, recently published in Infection Control and Hospital Epidemiology, was designed to examine seroconversion rates, seropositivity rates, and geometric mean titer (GMT) duration over a certain follow-up period ("Comparison of higher-dose intradermal...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-06-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry